Sat.Jan 18, 2025

article thumbnail

The Future of Plant-Based Cheeses

Drugs.com

SATURDAY, Jan. 18, 2025 -- A slice of tasty, stretchy, creamy cheese may soon be easier to come by for those on a dairy-free diet.Researchers in Canada are working to create plant-based cheeses with all the taste and texture of traditional, dairy.

96
article thumbnail

Morusin Reverses Epithelial‐Mesenchymal Transition in Gallbladder Cancer Cells by Regulating STAT3/HIF‐1α Signaling

Chemical Biology and Drug Design

Early metastasis induces dismal prognosis of gallbladder cancer. Morusin reverses epithelial-mesenchymal transition and suppresses metastasis of gallbladder cancer cells by modulating STAT3/HIF-1 signaling. ABSTRACT Gallbladder cancer is the most prevalent malignancy of the biliary tract and has a dismal overall survival even in the present day. The development of new drugs holds promise for improving the prognosis of this lethal disease.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Product lifecycle management: why you should consider selecting an OEM partner

Tecan

By David Keller As a healthcare instrument moves through its lifecycle, its engineering, development and customer support need to progress in parallel. In order to extend a products profitability for as long as possible and to maintain customer loyalty, you must plan for its evolution from the beginning. Involving an OEM partner in your product lifecycle management (LCM) from the start can help you to create products that are easier to service with a lower total cost of ownership (TCO), with few

article thumbnail

Species Dependent Metabolism of a Covalent nsP2 Protease Inhibitor with in Vivo Anti-alphaviral Activity

Covalent Modifiers

Mohammad Anwar Hossain, Abigail K. Mayo, Anirban Ghoshal, Sharon A. Taft-Benz, Elizabeth J. Anderson, Noah L. Morales, Katia D. Pressey, Ava M. Vargason, Kim L. R. Brouwer, Nathaniel J. Moorman, Mark T. Heise, Timothy M. Willson bioRxiv 2025.01.13.632788; doi: [link] RA-0002034 (1) is a potent covalent inhibitor targeting the alphavirus nsP2 cysteine protease.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven